Fenebrutinib met primary goals in two late-stage trials for the treatment of two different forms of multiple sclerosis.

Roche Holding AG said a multiple sclerosis drug showed it could work for most forms of the disease in two late-stage trials, ...

In other words, we can use AI as a simulated audience: a stand-in that reacts to a data story as if it were a specific type ...

Sertraline (Zoloft) may relieve emotional symptoms of depression and anxiety within two weeks, while physical side effects stabilize later. The research highlights how antidepressants can act on ...

A novel treatment combining chemotherapy and PRRT shows promising safety and efficacy for neuroendocrine tumors, with high response rates and ongoing trials. Michael Soulen, MD, spoke to Targeted ...

When researchers look for potential cancer therapy targets, they typically go after protein-coding genes that participate in ...

The former president was found to have defrauded lenders. Former President Donald Trump has been fined $354.8 million plus approximately $100 million in interest in a civil fraud lawsuit that could ...

Background Pain and fatigue are among the most debilitating symptoms of systemic sclerosis (SSc), severely impairing quality ...

MTVA READ THE FULL MTVA RESEARCH REPORT Business Update 8-Week Data for DA-1726 48 mg Cohort Expected in 4Q25 MetaVia, Inc.

Information on preferences can help trialists and protocol developers to design and plan future trials that integrate patients’ needs and thus reduce barriers to participation. The preference data of ...